[Is our current knowledge sufficient for the up-front use of aromatase inhibitors as adjuvant therapy for breast cancer?].

Subjects

Subjects :

Antineoplastic Agents, Hormonal therapeutic use
Breast Neoplasms mortality
Clinical Trials as Topic
Drug Therapy, Combination
Female
Humans
Tamoxifen therapeutic use
Aromatase Inhibitors therapeutic use
Breast Neoplasms prevention & control

Details

Language :

French

ISSN :

0368-2315

Volume :

38

Issue :

6

Database :

MEDLINE

Journal :

Journal de gynecologie, obstetrique et biologie de la reproduction

Publication Type :

Editorial & Opinion

Accession number :

19640658

Full Text :

https://doi.org/10.1016/j.jgyn.2009.06.002